These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4314847)

  • 1. Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission.
    Meek J; Fuxe K; Andén NE
    Eur J Pharmacol; 1970 Mar; 9(3):325-32. PubMed ID: 4314847
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.
    Lidbrink P; Jonsson G; Fuxe K
    Neuropharmacology; 1971 Sep; 10(5):521-36. PubMed ID: 4399540
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices.
    Carlsson A
    J Pharm Pharmacol; 1970 Oct; 22(10):729-32. PubMed ID: 4394776
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of imipramine and related antidepressive drugs on estrus behaviour in ovariectomised rats activated by progesterone, reserpine or tetrabenazine in combination with estrogen.
    Meyerson BJ
    Acta Physiol Scand; 1966; 67(3):411-22. PubMed ID: 6007785
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of central antireserpine effect by the use of light blink reflex (author's transl)].
    Dupeyron JP; Boulu R; Rossignol P
    Psychopharmacologia; 1973 Oct; 33(1):87-94. PubMed ID: 4769025
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of imipramine on central 5-hydroxytryptamine neurons.
    Carlsson A; Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1968 Feb; 20(2):150-1. PubMed ID: 4384540
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between inhibitors of the axonal amine pump and bretylium in the degeneration release of sympathetic transmitter.
    Lundberg D
    Acta Physiol Scand; 1970 Apr; 78(4):503-21. PubMed ID: 4194582
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 10. Microspectrofluorimetric studies on central 5-hydroxytryptamine neurons.
    Jonsson G; Einarsson P; Fuxe K; Hallman H
    Adv Biochem Psychopharmacol; 1974; 10():55-65. PubMed ID: 4276959
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intracerebral injections of 5,6-dihydroxytryptamine on central monoamine neurons: evidence for selective degeneration of central 5-hydroxytryptamine neurons.
    Daly J; Fuxe K; Jonsson G
    Brain Res; 1973 Jan; 49(2):476-82. PubMed ID: 4352736
    [No Abstract]   [Full Text] [Related]  

  • 12. Rophe neurons: effect of tricyclic antidepressant drugs.
    Sheard MH; Zolovick A; Aghajanian GK
    Brain Res; 1972 Aug; 43(2):690-4. PubMed ID: 5053300
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine.
    Carlsson A; Jonason J; Lindqvist M; Fuxe K
    Brain Res; 1969 Feb; 12(2):456-60. PubMed ID: 5306639
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for stabilization of cortical 5HT neurotransmission by chronic treatment with antidepressant drugs: induction of a high and low affinity component in 3H-5HT binding sites.
    Fuxe K; Ogren SO; Agnati LF; Calza L
    Acta Physiol Scand; 1982 Mar; 114(3):477-80. PubMed ID: 6291332
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of tricyclic antidepressants and 5-hydroxyindolealkylamine precursors on spinal monosynaptic reflex transmission.
    Clineschmidt BV; Pierce JE; Sjoerdsma A
    J Pharmacol Exp Ther; 1971 Nov; 179(2):312-23. PubMed ID: 4332325
    [No Abstract]   [Full Text] [Related]  

  • 16. On the mechanism of 5-hydroxytryptamine release by thymoleptics.
    Carlsson A; Jonason J; Lindqvist M
    J Pharm Pharmacol; 1969 Nov; 21(11):769-73. PubMed ID: 4390836
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac effects of antidepressants.
    Marmo E; Coscia L; Cataldi S
    Jpn J Pharmacol; 1972 Jun; 22(3):283-93. PubMed ID: 4539392
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological effects of a new antidepressant drug.
    Richter W
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:67-8. PubMed ID: 5630960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacological evaluation of a new antidepressant: butriptyline.
    Voith K; Herr F
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):318-31. PubMed ID: 5371184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.